Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement
About This Trial
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
audiological measurements
audiological measurements
Objective and subjective audiological measurements
Objective and subjective audiological measurements
Evaluation of the denoising methods REFINED
Evaluation of the denoising methods REFINED